Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mirapex 0.75mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Boehringer Ingelheim

Salt Composition

Pramipexole (0.75mg)

Overview Mirapex 0.75mg Tablet ER

Pramipexole 0.75mg Extended-Release tablets treat Parkinson's disease and restless legs syndrome (characterized by an irresistible urge to move legs, often due to unpleasant sensations). This medication reduces tremors by regulating body movements. Administer Pramipexole 0.75mg ER with food, consistently at the same time daily for optimal blood levels. Follow your physician's prescribed dosage and schedule; if a dose is missed, take it immediately upon recall. Complete the entire course of treatment as directed, even if symptoms improve; abruptly ceasing therapy is unsafe without consulting your doctor. Potential side effects include nausea, dry mouth, tiredness, visual disturbances, constipation, and swelling in the extremities. Drowsiness and dizziness are also possible; avoid driving or mentally demanding tasks until the medication's effects are known. Report any unusual mood shifts, heightened libido, compulsive gambling, or excessive spending to your doctor immediately, as these can be serious.

Uses of Mirapex 0.75mg Tablet ER

Parkinson's Disease and restless legs syndrome

Major Benefits of Mirapex 0.75mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Mirapex 0.75mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Mirapex 0.75mg Tablet ER:

  • Dizziness
  • Sleepiness
  • Nausea
  • Dryness in mouth
  • Fatigue
  • Hallucination
  • Constipation
  • Peripheral edema
  • Muscle spasm

How to use Mirapex 0.75mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Mirapex 0.75mg Extended-Release tablet with a meal.

How Mirapex 0.75mg Tablet ER works:

Pramipexole extended-release 0.75mg tablets function by augmenting dopaminergic neurotransmission, thus improving motor control within the central nervous system.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Ropinirole 0.75mg extended-release tablets can induce increased sleepiness when combined with alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Mirapex 0.75mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Mirapex 0.75mg Extended-Release tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant. This medication's prolactin-suppressing effect could negatively impact lactation.

DrivingDrivingUNSAFE

Prolonged-release Mirapex 0.75mg tablets may induce adverse reactions impacting driving capabilities. These tablets can lead to hallucinations—perceiving nonexistent stimuli—potentially impairing driving safety.

KidneyKidneyCAUTION

Extended-release Mirapex tablets (0.75mg) require careful administration in individuals with impaired renal function. Dosage modification of Mirapex 0.75mg ER tablets may be necessary. Physician consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

Pramipexole extended-release 0.75mg tablets are likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may not be necessary, however, physician consultation is advised.

What if you forget to take Mirapex 0.75mg Tablet ER :

Omit any missed 0.75mg extended-release Mirapex tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mirapex 0.75mg Tablet ER

LabelValue
Type of Compound Benzothiazole-based compound
Potential for Dependence None.
Type of Medication Nervous system
Mechanism of Action Drugs that stimulate dopamine receptors

FAQs on Mirapex 0.75mg Tablet ER

Weight loss, potentially from reduced appetite, is a frequent side effect of Mirapex 0.75mg Extended-Release tablets. Weight gain is a less common occurrence. Consult your physician or a registered dietitian if you have weight-related concerns.
Ropinirole 0.75mg extended-release tablets can induce drowsiness. Unexpected sleep episodes are also possible. If this happens, avoid operating vehicles or complex equipment, and consult your physician.
Individuals with restless legs syndrome (RLS) experience unpleasant sensations in their legs, prompting an overwhelming need to move them, particularly at night or when inactive. Mirapex 0.75mg Extended-Release tablets are classified as dopamine agonists, mimicking the action of this neurotransmitter. By activating dopamine receptors crucial for motor control within the brain, this medication alleviates RLS symptoms.
Mirapex 0.75mg extended-release tablets do not function as muscle relaxants. Their purpose is to enhance motor skills and muscular control for individuals with Parkinson's disease. This medication is a dopamine agonist, affecting dopamine receptor sites.
Consult your physician before ceasing Mirapex 0.75mg Extended-Release tablets. Abrupt cessation of Mirapex 0.75mg Extended-Release tablets can lead to neuroleptic malignant syndrome. This syndrome's manifestations encompass akinesia, muscle rigidity, pyrexia, labile blood pressure, tachycardia, altered mental status, and reduced consciousness.
Follow your physician's instructions for using Mirapex 0.75mg Extended-Release tablets. Dosage will be determined by your doctor based on your specific medical needs. Ideally, take the medication two to three hours before sleep. Ingest the tablets whole with water. Consumption with or without food is acceptable; however, eating beforehand might lessen nausea.
Mirapex 0.75mg Extended-Release tablets can cause severe adverse reactions such as visual and auditory hallucinations, cognitive impairment (including confusion and altered thought processes), aggression, restlessness, visual disturbances, involuntary movements, and uncontrollable postural changes (e.g., neck flexion, forward bending, lateral tilting during sitting, standing, or walking). Further, dark, reddish, or cola-colored urine; muscle pain, stiffness, or weakness; may also occur. Seek immediate medical attention if any of these symptoms develop.
Prolonged-release Mirapex 0.75mg tablets can induce impulse control disorders, potentially leading to unusual cravings or urges. This medication may lower resistance to harmful behaviors, such as compulsive gambling, overspending, or overeating. Furthermore, it may be associated with heightened libido or increased preoccupation with sexual thoughts and feelings.
Mirapex 0.75mg Tablet ER
103
MRP 125
17% off